Search

Your search keyword '"Tan, Wenliang"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Tan, Wenliang" Remove constraint Author: "Tan, Wenliang" Topic carcinoma, hepatocellular Remove constraint Topic: carcinoma, hepatocellular
11 results on '"Tan, Wenliang"'

Search Results

1. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma.

2. A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma.

3. Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy.

4. CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA.

5. GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma.

6. CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway.

7. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.

8. TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

9. Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway.

10. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study.

11. TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.

Catalog

Books, media, physical & digital resources